Lucrezia Laterza

27PUBLICATIONS
155CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Community and primary careApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 10, 2026
Real-World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease-A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).

|Aug 21, 2026
Nursing-Led Support Across the Standard Care-Clinical Trial-Standard Care Pathway in Inflammatory Bowel Disease: A Review With Realist-Informed Interpretation.

|Jul 28, 2026
VSL#3® May Reduce Abdominal Pain and Bloating in Ulcerative Colitis Remission with IBS-like Symptoms: An Exploratory Randomized, Double-Blind Placebo-Controlled Trial.

|Jul 28, 2026
Rewriting Inflammation in IBD: Lipidomics from Pathogenesis to Clinical Application.

|Apr 28, 2026
OCTN1 variants shape innate immunity and predict individual response to anti-TNFα in ulcerative colitis patients: An exploratory study.

|Feb 18, 2026
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.

Franco Scaldaferri, Federica Di Vincenzo, Marina Aloi

Pageof 5

Frequent Collaborators

16 joint publications

Franco Scaldaferri

12 joint publications

Antonio Gasbarrini

7 joint publications

Alfredo Papa

7 joint publications

Daniela Pugliese